Transcat, Inc. (NASDAQ:TRNS) Given Consensus Rating of “Moderate Buy” by Analysts

Shares of Transcat, Inc. (NASDAQ:TRNSGet Free Report) have received a consensus recommendation of “Moderate Buy” from the five ratings firms that are currently covering the stock, MarketBeat.com reports. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $130.25.

TRNS has been the topic of several recent analyst reports. StockNews.com lowered Transcat from a “hold” rating to a “sell” rating in a research note on Tuesday, October 29th. Craig Hallum boosted their target price on Transcat from $113.00 to $125.00 and gave the stock a “buy” rating in a research note on Thursday, December 12th. Northland Securities reduced their price target on shares of Transcat from $130.00 to $110.00 and set a “market perform” rating on the stock in a research note on Wednesday, October 30th. HC Wainwright reiterated a “buy” rating and set a $156.00 price objective on shares of Transcat in a research report on Tuesday, October 29th. Finally, Oppenheimer restated an “outperform” rating and issued a $130.00 target price (down previously from $155.00) on shares of Transcat in a research report on Wednesday, October 30th.

Read Our Latest Research Report on TRNS

Transcat Stock Up 0.4 %

TRNS opened at $105.70 on Friday. Transcat has a twelve month low of $94.29 and a twelve month high of $147.12. The stock has a market capitalization of $972.33 million, a price-to-earnings ratio of 53.38 and a beta of 0.71. The company has a 50-day simple moving average of $105.56 and a 200 day simple moving average of $117.18.

Transcat (NASDAQ:TRNSGet Free Report) last posted its quarterly earnings results on Monday, October 28th. The scientific and technical instruments company reported $0.35 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.47 by ($0.12). Transcat had a return on equity of 7.36% and a net margin of 6.63%. The firm had revenue of $67.83 million for the quarter, compared to analyst estimates of $70.30 million. During the same quarter in the prior year, the business posted $0.41 EPS. The business’s revenue was up 8.0% on a year-over-year basis. Sell-side analysts anticipate that Transcat will post 1.76 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in TRNS. Conestoga Capital Advisors LLC increased its position in Transcat by 17.9% in the 3rd quarter. Conestoga Capital Advisors LLC now owns 907,191 shares of the scientific and technical instruments company’s stock valued at $109,561,000 after acquiring an additional 137,830 shares during the period. Royce & Associates LP increased its holdings in Transcat by 8.2% in the third quarter. Royce & Associates LP now owns 511,701 shares of the scientific and technical instruments company’s stock valued at $61,798,000 after purchasing an additional 38,774 shares during the period. Champlain Investment Partners LLC raised its position in Transcat by 22.1% during the 3rd quarter. Champlain Investment Partners LLC now owns 409,500 shares of the scientific and technical instruments company’s stock worth $49,455,000 after purchasing an additional 74,169 shares during the last quarter. Geode Capital Management LLC lifted its holdings in Transcat by 5.4% during the 3rd quarter. Geode Capital Management LLC now owns 217,473 shares of the scientific and technical instruments company’s stock worth $26,269,000 after buying an additional 11,106 shares during the period. Finally, State Street Corp grew its position in shares of Transcat by 8.1% in the 3rd quarter. State Street Corp now owns 207,230 shares of the scientific and technical instruments company’s stock valued at $25,027,000 after buying an additional 15,514 shares during the last quarter. Institutional investors own 98.34% of the company’s stock.

Transcat Company Profile

(Get Free Report

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.

Featured Articles

Analyst Recommendations for Transcat (NASDAQ:TRNS)

Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.